Case Report

Pemphigus Vulgaris: An Acquired Blistering Disease

Authors: Kirby J. Scott, LCDR, MC, USN, Brian J. McKinnon, LCDR, MC, USNR

Abstract

Pemphigus vulgaris is one of a group of autoimmune disorders that are caused by autoantibodies against the desmoglein adhesion molecules of squamous epithelial cells. It is a rare form of immune dysfunction that can prove vexing to the patient and physician, but it has distinct clinical and histologic findings. We report a case of a patient with the autoimmune blistering disease pemphigus vulgaris localized to the oral cavity and discuss the important clinical, immunopathologic, and therapeutic factors of this disease. This case report highlights the unusual nature of pemphigus vulgaris, the modalities used in its diagnosis, and effectiveness of therapy. Pemphigus vulgaris is an uncommon disease blistering disorder due to desmoglein autoantibodies, whose presentation can be alarming and puzzling to the clinician. Awareness of the disease's presentation and mechanism will allow for an efficient diagnostic evaluation and timely treatment.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Udey MC, Stanley JR. Pemphigus: Diseases of antidesmosomal autoimmunity. JAMA 1999; 282: 572–576.
2. Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 1999; 135: 54–56.
3. Anhalt GJ, Diaz LA. Prospects for autoimmune disease: Research advances in pemphigus. JAMA 2001; 285: 652–654.
4. Fleischli ME, Valek RH, Pandya AG. Pulse intravenous cyclophosphamide therapy in pemphigus. Arch Dermatol 1999; 135: 57–61.
5. Stanley JR. Therapy of pemphigus vulgaris. Arch Dermatol 1999; 135: 76–78.

Life must be dedicated to a destiny in order to have ameaning. —José Ortega y Gasset